Regional differences of L-type high voltage-gated calcium channel subunit expression in the mouse brain after chronic morphine treatment

Journal of Pharmacological Sciences

Volumn 105, Issue 2, 2007, Pages 177-183

  Shibasaki, Masahiro ^a   Katsura, Masashi ^a   Kurokawa, Kazuhiro ^a   Torigoe, Fumiko ^a   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Calcium channel subunit; Morphine; Physical dependence; 3H PN200 110 binding

Indexed keywords

CALCIUM CHANNEL L TYPE; ISRADIPINE; MORPHINE; PROTEIN SUBUNIT; TRITIUM; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG DOSE INCREASE; LONG TERM EXPOSURE; MALE; MORPHINE ADDICTION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCATCHARD PLOT; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

EID: 36148973113     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070885     Document Type: Article

References (36)

1. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Pharmacol Rev. 2001;81:299-343.
2. Przewlock R. Opioid abuse and brain gene expression. Eur J Pharmacol. 2004;500:331-349.
3. Ramkumar V, El-Fakahany EE. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. Eur J Pharmacol. 1988;146:73-83.
4. Zharkovsky A, Tötterman AM, Moisio J, Ahtee L. Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:483-486.
5. Díaz A, Ruíz F, Jesús F, Pazos A, Hurlé M. Regulation of dihydropyridine-sensitive Ca2+ channels during opioid tolerance and supersensitivity in rats. J Pharmacol Exp Ther. 1995;274:1538-1544.
6. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol. 1998;352:189-197.
7. Little HJ. The role of neuronal calcium channels in dependence on ethanol and other sedatives/hypnotics. Pharmacol Ther. 1991;50:347-365.
8. Crews FT, Morrow AL, Criswell H, Breese G. Effects of ethanol on ion channels. Int Rev Neurobiol. 1996;39:283-367.
9. Walter HJ, Messing RO. Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem Int. 1999;35:95-101.
10. Katsura M, Torigoe F, Hayashida S, Honda T, Tsujimura A, Ohkuma S. Ethanol physical dependence is accompanied by upregulated expression of L-type high voltage-gated calcium channel α1 subunits in mouse brain. Brain Res. 2005;1039:211-215.
11. 2+ channels: role in channel function. Trend Neurosci. 1998;21:148-154.
12. Hoffmann F, Lacinová L, Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol. 1999;139:33-87.
13. 2+ channels. Ann Rev Cell Develop Biol. 2000;16:521-555.
14. 2+ channels. J Physiol. 2000;528:237-249.
15. 2+ channels. Trend Neurosci. 2001;24:176-181.
16. Wang M-C, Dolphin A, Kitmitto A. L-type voltage-gated calcium channels: understanding function through structure. FEBS Lett. 2004;564:245-250.
17. Katsura M, Mohri Y, Shuto K, Yan H-D, Amano T, Tsujimura A, et al. Up-regulation of L-type voltage-dependent calcium channels after long term exposure to nicotine in cerebral cortical neurons. J Biol Chem. 2002;277:7979-7988.
18. Hayashida S, Katsura M, Torigoe F, Tsujimura A, Ohkuma S. Increased expression of L-type high voltage-gated calcium channel α1 and α2/δ subunits in mouse brain after chronic nicotine administration. Brain Res Mol Brain Res. 2005;135:280-284.
19. Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol. 1998;12:37-67.
20. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neuroscie. 2005;8:1445-1449.
21. Maladonado R, Dauge V, Callebert J, Villette JM, Fournie-Zaluski MC, Feger J, et al. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome. Eur J Pharmacol. 1986;165:199-207.
22. Katsura M, Hara A, Higo A, Tarumi C, Hibino Y, Ohkuma S. Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain. J Neurochem. 1998;71:2638-2641.
23. He M, Bodi I, Mikala G, Schwartz A. Motif IIIS5 of L-type calcium channels is involved in the dihydropyridine binding site. J Biol Chem. 1997;272:2629-2633.
24. 2+ channel agonists. Mol Pharmacol. 2003;64:235-248.
25. Katsura M, Shibasaki M, Hayashida S, Torigoe F, Tsujimura A, Ohkuma S. Increase in expression of α1 and α2/δ1 subunits of L-type high voltage-gated calcium channels after sustained ethanol exposure in cerebral cortical neurons. J Pharmacol Sci. 2006;102:221-230.
26. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
27. 3H]nitrendipine binding and γ-aminobutyric acid release in rat hippocampus following repeated morphine administration. J Neurochem. 1989;53:1507-1511.
28. Gerstin EH Jr, MaMahon T, Dadgar J, Messing O. Protein kinase Cδ mediates ethanol-induced up-regulation of L-type calcium channels. J Biol Chem. 1998;273:16409-16414.
29. Shibasaki M, Katsura M, Tsujimura A, Ohkuma S. Up-regulated L-type high voltage-gated calcium channels cause increase in diazepam binding inhibitor induced by sustained morphine exposure in mouse cerebrocortical neurons. Life Sci. 2006;80:166-172.
30. 2+ current enhancement by α2/δ and β subunits in Xenopus oocytes: contribution of changes in channel gating and α1 protein level. J Physiol. 1995;489:55-62.
31. 2+ channel α2/δ subunit. J Neurosci. 1997;17:6884-6891.
32. Klugbauer N, Lacinová L, Marais E, Hobom M, Hofmann F. Molecular diversity of the calcium channel α2/δ subunit. J Neurosci. 1999;19:684-691.
33. 2+ channel. Nature. 1991;352:527-530.
34. Schaeffer P, Kuhnier C, Stoclet JC. Interactions of calmodulin antagonists with calcium antagonists binding sites. Eur J Pharmacol. 1991;206:325-332.
35. Varadi G, Lory P, Schultz D, Varadi M, Schwartz A. Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel. Nature. 1991;352:159-162.
36. Seward E, Hammond C, Henderson G. μ-Opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proc Biol Sci. 1991;244:129-135.